Presentation of familial Mediterranean fever in a heterozygous MEFV mutation triggered by immunosuppressive therapy for myelodysplastic syndrome

Int J Hematol. 2009 Jul;90(1):91-93. doi: 10.1007/s12185-009-0336-z. Epub 2009 May 23.

Abstract

Familial Mediterranean fever (FMF) is a recessively inherited disease characterized by recurrent episodes of systemic inflammation. The cause of this disease is the mutations affecting both the alleles of MEFV gene. We describe here a case in a heterozygous MEFV mutation complicated with myelodysplastic syndrome (MDS). Clinical symptoms and the effectiveness of colchicines in this patient are typical for FMF. The first attack of FMF in this patient was observed during immunosuppressive therapy for MDS. This case suggests the possibility that certain immunosuppressants may trigger FMF attack in asymptomatic cases carrying MEFV heterozygous mutation.

Publication types

  • Case Reports

MeSH terms

  • Alleles
  • Cytoskeletal Proteins / genetics*
  • Familial Mediterranean Fever / etiology*
  • Familial Mediterranean Fever / genetics
  • Heterozygote*
  • Humans
  • Immunosuppression Therapy / adverse effects*
  • Male
  • Mutation*
  • Myelodysplastic Syndromes / complications
  • Myelodysplastic Syndromes / genetics
  • Myelodysplastic Syndromes / therapy*
  • Pyrin
  • Young Adult

Substances

  • Cytoskeletal Proteins
  • MEFV protein, human
  • Pyrin